Previous 10 | Next 10 |
SAN DIEGO, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), provider of optical genome mapping (OGM) solutions on the Saphyr ® system and the leading software for genomic data visualization, interpretation and reporting, today announced the publication of a study of...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The tech underpinning Bionano Genomics (NASDAQ: BNGO ) stock is a cool genomics sequencing device called Saphyr . It claims to do genomic mapping faster, and better, than ever before possible. The machine costs $150...
Stocks with the ability to generate 10X returns on capital are a rare breed. However, they do exist. In recent times, several biotech stocks have produced gains well in excess of 1,000% for their early shareholders. For example, a $100,000 investment in Axsome Therapeutics back in Janua...
SAN DIEGO, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr ® system and provider of the leading software for genomic data visualization, interpretation and reporting, today announced that it has appoin...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips After months of consolidation, Bionano Genomics (NASDAQ: BNGO ) is breaking down. BNGO stock has plummeted 30% since announcing earnings in early November. While the earnings report was decent, some legitimate co...
SAN DIEGO, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), provider of optical genome mapping (OGM) solutions on the Saphyr ® system and the leading software for genomic data visualization, interpretation and reporting, today announced the publication of a study by...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It may not be the “end all, be all” development for Bionano Genomics (NASDAQ: BNGO ). But its strong fiscal performance last quarter isn’t something that should be ignored. Unfortunately, tha...
SAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) and provider of industry-leading data interpretation solutions for next-generation sequencing (NGS) and microarrays, today announced the lineup of content scheduled to be pres...
Cold response to Saphyr from the medical community and the acquisition of BioDiscovery and Lineagen position BNGO into becoming a clinical lab instead of a Life Science equipment manufacturer. The acquisition of Lineagen and BioDiscovery diversifies BNGO's portfolio, brings it closer ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bionano Genomics (NASDAQ: BNGO ) continues to take steps that will, in the long-term, tremendously boost its results and the share price. Consequently, I remain very bullish on BNGO stock. Source: Natali_ Mis/Shutt...
News, Short Squeeze, Breakout and More Instantly...
Bionano Genomics Inc. Company Name:
BNGO Stock Symbol:
NASDAQ Market:
Bionano Genomics Inc. Website:
SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- A sponsored exhibitor session will feature Dr. Phillip Michaels from Harvard Medical School and Brigham and Women’s Hospital presenting data from a multi-site study evaluating the performance and benefits of optical genome mapping (O...
SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the Canaccord Genuity 44 th Annual Growth Conference on August 13, 2024. Conference & ...
SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, August 7, 2024, at 4:30 p.m. Eastern Time to report financial results for the second quarter 2024 and to highlight r...